Menu Back to 8th-DIA-Annual-Conference-in-Japan-for-Asian-New-Drug-Development

Program Committee

  • Hidetoshi  Shuto
    Hidetoshi Shuto Senior Fellow, Corporate Technology Sector Nitto Denko Corporation, Japan
  • Ari  Fujishiro
    Ari Fujishiro Daiichi Sankyo Co., Ltd., Japan
  • Tomohisa  Hayakawa, PhD
    Tomohisa Hayakawa, PhD Senior Vice President Business Development EPS International Holdings Co., Ltd., Japan
  • Shii  Man, MD, PhD
    Shii Man, MD, PhD Otsuka Beijing Research Institute, China
  • Koichi  Miyazaki, MSc, RPh
    Koichi Miyazaki, MSc, RPh Senior Director, Regulatory Affairs Group, Asia Development Dept Daiichi Sankyo Co., Ltd., Japan
  • Yasuto  Otsubo
    Yasuto Otsubo Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Min Soo  Park, MD, PhD
    Min Soo Park, MD, PhD Professor, Pediatrics and Clinical Pharmacology Yonsei University College of Medicine, Korea, Republic of
  • Kihito  Takahashi, MD, PhD
    Kihito Takahashi, MD, PhD VP and Senior Managing Director, Japan Development & Medical Affairs Division GlaxoSmithKline K.K., Japan
  • Akio  Uemura, PhD
    Akio Uemura, PhD Corporate Officer, Senior Director and Head, Drug Development Operations Japan Allergan Japan K.K., Japan
  • Yoshiaki  Uyama, PhD
    Yoshiaki Uyama, PhD Director, Office of Medical Informatics and Epidemiology Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Jisin  Yang, MD
    Jisin Yang, MD Global Clinical Program Director, Japan R&D CSL Behring K.K., Japan
Load More